← Back to Search

Physical Activity Prescription for Post-ACL Reconstruction Recovery

N/A
Recruiting
Led By Jane Thornton, MD PhD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Unable/unwilling to follow up for the study period
Scheduled for second surgery over study period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate the effect of a physical activity prescription delivered through a mobile app on patient-reported outcomes and cartilage health in individuals 5-10 years post-ACL reconstruction.

Who is the study for?
This trial is for individuals who are 7 years post-ACL reconstruction surgery and part of the STAbiLiTY study. They must have internet and smartphone access, be stable enough to engage in physical activity, willing to follow up during the study period, and communicate in English.
What is being tested?
The trial is testing a Physical Activity Prescription (PARx) intervention aimed at improving knee health after ACL reconstruction. It investigates whether regular prescribed exercise can prevent or delay osteoarthritis by promoting better cartilage health.
What are the potential side effects?
While specific side effects aren't listed for PARx, increased physical activity could potentially lead to muscle soreness, joint pain, or exacerbation of existing knee issues if not done carefully.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot or do not want to commit to the study's follow-up schedule.
Select...
I am scheduled for a second surgery during the study.
Select...
I am unable to communicate in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
International Knee Documentation Committee (IKDC)
Secondary study objectives
Knee Injury and Osteoarthritis Outcome Score
Physical Activity Evaluation using Global Physical Activity Questionnaire (GPAQ) and MyRecovery app
Three-dimensional Motion-captured Gait Biomechanics Analysis
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physical Activity Prescription (PARx)Experimental Treatment1 Intervention
Patients will be prescribed technology-based physical activity programming.
Group II: Usual CareActive Control1 Intervention
Patients will receive the usual care.

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
252 Previous Clinical Trials
58,296 Total Patients Enrolled
Jane Thornton, MD PhDPrincipal InvestigatorWestern University
1 Previous Clinical Trials
192 Total Patients Enrolled

Media Library

Physical Activity Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05152758 — N/A
Anterior Cruciate Ligament Reconstruction Research Study Groups: Physical Activity Prescription (PARx), Usual Care
Anterior Cruciate Ligament Reconstruction Clinical Trial 2023: Physical Activity Intervention Highlights & Side Effects. Trial Name: NCT05152758 — N/A
Physical Activity Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05152758 — N/A
~5 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top